CVE-2021-25921

MEDIUMCVSS 5.4/10EPSS 91.10%

Last modified

CVE-2021-25921 is a medium-severity vulnerability rated 5.4/10 on the CVSS scale. In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.. EPSS estimates a 91.10% chance of exploitation in the next 30 days.

Description

In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.

Metrics

CVSS 3.1
5.4/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS Probability
91.10%

99.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
Open-EmrOpenemr>= 2.7.3, <= 6.0.0

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2021-25921?
In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.
How severe is CVE-2021-25921?
CVE-2021-25921 has a CVSS score of 5.4/10 (MEDIUM severity). The EPSS model estimates a 91.10% probability of exploitation in the next 30 days.
How do I fix CVE-2021-25921?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2021-25921?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST